Evidence map›Paper›PMID 31931614›Full record

ReviewJournal of diabetes science and technology2021

Continuous Glucose Monitoring Devices: Past, Present, and Future Focus on the History and Evolution of Technological Innovation.

Olesya Didyuk, Nicolas Econom, Angelica Guardia, Kelsey Livingston, Ulrike Klueh

Abstract readReview
In one paragraph

Review in Journal of diabetes science and technology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Guideline
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Impact of Continuous Glucose Monitoring for American Indian/Alaska Native Adults With Type 2 Diabetes Mellitus Not Using Insulin.Federal practitioner : for the health care professionals of the VA, DoD, and PHS · 2025
    Article
  18. Article
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Olesya DidyukDepartment of Biological Sciences, IBio (Integrative Biosciences Center), Wayne State University, Detroit, MI, USA.
Nicolas EconomBiomedical Engineering, IBio (Integrative Biosciences Center), Wayne State University, Detroit, MI, USA.
Angelica GuardiaBiomedical Engineering, IBio (Integrative Biosciences Center), Wayne State University, Detroit, MI, USA.
Kelsey LivingstonBiomedical Engineering, IBio (Integrative Biosciences Center), Wayne State University, Detroit, MI, USA.
Ulrike KluehBiomedical Engineering, IBio (Integrative Biosciences Center), Wayne State University, Detroit, MI, USA.ORCID 0000-0003-1104-7704

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
Infusion device optimization by addressing root causes of the inflammatory responseR01DK129681 · NIDDK · WAYNE STATE UNIVERSITY · PI Ulrike Klueh · 2022 to 2026
$2.6M
NIDDK NIH HHS P30 DK020572NIDDK NIH HHS R01 DK129681
6 · The paper itself

Abstract

The concept of implantable glucose sensors has been promulgated for more than 40 years. It is now accepted that continuous glucose monitoring (CGM) increases quality of life by allowing informed diabetes management decisions as a result of more optimized glucose control. The focus of this article is to provide a brief overview of the CGM market history, emerging technologies, and the foreseeable challenges for the next CGM generations as well as proposing possible solutions in an effort to advance the next generation of implantable sensor.

Indexed as

Blood GlucoseBlood Glucose Self-MonitoringHumansInsulin Infusion SystemsInventionsQuality of LifeBlood Glucosecontinuous glucose monitoringdiabetesforeign body reactioninflammation

Identifiers

PMID31931614
PMCPMC8120065

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.